U.S. Attention Deficit Hyperactivity Disorder (ADHD) Markets

 

USD 2,450

* Required Fields

USD 2,450

PAY BY INVOICE

Be the first to review this product

The U.S. Attention Deficit Hyperactivity Disorder markets report provides revenue forecasts, patient forecasts, competitive analysis, market trends, and product analysis. The market is segmented by product class, namely the stimulant therapies market and the non-stimulant therapies market. Within these segments, emphasis is placed on evaluation of the once and twice-thrice daily products in the stimulant therapies market segment and Strattera and other emerging products in the non-stimulant therapies market segment. Major market challenges, drivers and restraints, and strategic recommendations to overcome market challenges are discussed.

Table of Contents

U.S. Attention Deficit Hyperactivity Disorder (ADHD) Markets, Executive SummaryExecutive SummaryExecutive SummaryU.S. Attention Deficit Hyperactivity Disorder (ADHD) Markets, Total MarketADHD OverviewIntroductionReport Scope and SegmentationCustomer Segmentation and Targeting StrategiesDiagnostic Developments Shaping the ADHD Prescription MarketMacroeconomic AnalysisPolitical and Regulatory Trends Social Dynamics and TrendsEconomic and Reimbursement Trends and ImpactTechnological Trends and StrategiesMarket Forecasts and TrendsDemand Analysis (Children Adolescents and Adults)Pricing TrendsRevenue ForecastMarket Engineering AnalysisCompetitive AnalysisCompetitive Scenario and Industry AttractivenessSelected Competitor Profiles and Strategic RelationshipsProduct Life Cycle AnalysisGrowth StrategiesProduct AnalysisApproved Products & Patent and Market Exclusivity ExpirationsProduct PipelineAnalysis of Unmet Patient Needs and Treatment TrendsChallenges and Strategic RecommendationsLimited Product Differentiation and Increasing Generic Presence Puts Downward Pressure on PricesSubjectivity of Diagnosis Inhibits Demand and Constrains Revenue PotentialGrowing Difficulty in Securing Reimbursement Curbs Revenue GrowthConcern About Artificially Increasing Demand for Medication Incites Stricter Regulatory EnforcementU.S. Attention Deficit Hyperactivity Disorder (ADHD) Markets, Stimulant Therapies ADHD MarketOverviewIntroductionMarket DriversMarket RestraintsGrowth of Once-Daily Market and SWOT Analysis of Key ProductsGeneric Presence and Growing ThreatMarket Engineering AnalysisForecasts and TrendsPatient ForecastsPricing AnalysisRevenue ForecastU.S. Attention Deficit Hyperactivity Disorder (ADHD) Markets, Non-Stimulant Therapies ADHD MarketOverviewIntroductionMarket DriversMarket RestraintsSWOT analysis for StratteraMarket Engineering AnalysisForecasts and TrendsPatient ForecastsPricing AnalysisRevenue Forecasts




Keyword1

Keyword2

Keyword3

Related Research

Release Date : 13-Dec-17

Region : North America

Release Date : 13-Dec-17

Region : North America

Release Date : 12-Dec-17

Region : North America

Release Date : 12-Dec-17

Region : North America

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.